U.S. Sucralfate Market by Formulation (Tablet and Liquid Suspension), by Indication (Gastric Ulcers, Duodenal Ulcers, Gastro Esophageal Reflux Disease (GERD), and Others Indications), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and by State (Illinois, Texas, New York, California, and Others) - Size, Share, Outlook, and Opportunity Analysis, 2018-2026

  • Published On : Aug 2019 |
  • Pages : 129 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

U.S. Sucralfate Market – Market Insights

Sucralfate is the generic form of the brand-name drug, Carafate. It is a prescription medicine used to treat ulcers of the upper gastrointestinal tract, peptic ulcer disease, and to prevent reoccurrence of ulcers.

The U.S. sucralfate market size was valued at US$ 296.2 million in 2017, and is expected to exhibit a CAGR of 3.1% over the forecast period (2018–2026).

Figure 1. U.S. Sucralfate Market Value (US$ Mn), by Distribution Channel, 2018

U.S. Sucralfate  | Coherent Market Insights

Market Value (US$ Mn),

Source: Coherent Market Insights Analysis (2019)

Increasing prevalence of gastrointestinal disorders and H. pylori-associated infections is expected to propel the market growth

Rising incidence of gastric ulcers caused due to use of nonsteroidal anti-Inflammatory drugs (NSAID) and H. pylori infection is expected to drive the U.S. sucralfate market. According to the study by Deccan College of Medical Sciences, 2016, an estimated 95% of duodenal and 70% of gastric ulcers are caused due to Helicobacter pylori. Furthermore, the same study also stated that around 14-25% of gastric and duodenal ulcers are associated with NSAID use.

Rising prevalence of peptic ulcers is expected to bolster the market growth. According to the data published by ScienceDirect Journal in 2016, duodenal ulcers are more common type of peptic ulcers and its prevalence was around 6% to 12% in the U.S.

Figure 2. U.S. Sucralfate Market Share (%), by Distribution Channel, 2018 and 2026

U.S. Sucralfate  | Coherent Market Insights 

Source: Coherent Market Insights Analysis (2019)

Increasing collaboration and acquisition strategies adopted by market players is expected to bolster the market growth

The U.S. sucralfate market is expected to witness significant growth, owing to increasing inorganic growth strategies such as collaboration and acquisitions by market players. For instance, in 2014, Aptalis Pharma Inc., a specialty pharmaceutical company and manufacturer of Carafate, was acquired by Forest Laboratories, Inc., a fully integrated, specialty pharmaceutical company. Forest agreed to acquire Aptalis from TPG, the global private investment firm, for US$ 2.9 billion in cash.

Increasing applications and uses of sucralfate in the U.S. is expected to drive the market growth. According to the American Broncho Esophagological Association report, in April 2018, use of sucralfate along with honey aids in treatment of esophageal injury in infants and children. Esophageal injury in infants and children are associated with consumption of Button Batteries (BB), small disc-shaped batteries commonly found in toys.

Moreover, increasing prevalence of gastro-esophageal reflux disease (GERD) and Helicobacter pylori infection is expected to bolster the U.S. sucralfate market over the forecast period. For instance, according to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the prevalence of GERD was reported in the range from 15% to 30% in the U.S. in 2014. Similarly, according to the data published in American Gastroenterological Association (AGA) Journal in 2017, the prevalence of Helicobacter pylori positive infection is 35.6% among the population in the U.S.

Key Players

Major players operating in the U.S. sucralfate market include Teva Pharmaceutical Industries Ltd., Allergan plc, Vertice Pharma LLC, and Pharmaceutical Associates Inc.

Sucralfate is a hydroxy aluminum salt of sucrose octasulfate that functions as a local mucosal adherent. It forms a coating over ulcers by sticking to the affected area, which protects the area from acid and enzymes and helps ulcers to heal more quickly. Sucralfate can also be used in treating ulcers and upper gastrointestinal disorders of dog, horse, and cat, which may arise due to drugs (particularly non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids), toxic chemical ingestion, liver disease, renal failure, carcinoma, stress (trauma, shock, sepsis, and burns), and inflammatory bowel disease.

Market Dynamics

Increasing clinical trials for exploring different uses of sucralfate for different indications is a major factor driving U.S. sucralfate market growth. For instance, according to the study published by the National Center of Biotechnology Information, in 2016, a clinical trial conducted on Radiation Proctitis patients receiving sucralfate treatment showed 92.3% positive results in 16 weeks.

Furthermore, monitoring of drugs including sucralfate in the U.S. by the government authorities for avoiding fatal conditions in the population is expected to drive the market growth. For instance, in 2017, the U.S. FDA updated name of 'Carafate suspension' to 'Carafate oral suspension' to avoid fatal complications with mistakenly intravenous administration of the drug.

Key features of the study:

  • This report provides in-depth analysis of the U.S. sucralfate market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2018–2026), considering 2017 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the U.S. sucralfate market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Allergan plc, Vertice Pharma LLC, and Pharmaceutical Associates Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics.
  • The U.S. sucralfate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the U.S. sucralfate market

Detailed Segmentation:

  • U.S. Sucralfate Market, By Formulation:
    • Tablet
    • Liquid Suspension
      • Unit Dose Cup
      • Bottle
  • U.S. Sucralfate Market, By Indication:
    • Gastric Ulcers
    • Duodenal Ulcers
    • Gastro Esophageal Reflux Disease (GERD)
    • Others
  • U.S. Sucralfate Market, By Distribution Channel:
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy
  • U.S. Sucralfate Market, By State:
    • Illinois
      • By Formulation:
        • Tablet
        • Liquid Suspension
          • Unit Dose Cup
          • Bottle
      • By Indication:
        • Gastric Ulcers
        • Duodenal Ulcers
        • Gastro Esophageal Reflux Disease (GERD)
        • Others
      • By Distribution Channel:
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
    • Texas
      • By Formulation:
        • Tablet
        • Liquid Suspension
          • Unit Dose Cup
          • Bottle
      • By Indication:
        • Gastric Ulcers
        • Duodenal Ulcers
        • Gastro Esophageal Reflux Disease (GERD)
        • Others
      • By Distribution Channel:
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
    • New York
      • By Formulation:
        • Tablet
        • Liquid Suspension
          • Unit Dose Cup
          • Bottle
      • By Indication:
        • Gastric Ulcers
        • Duodenal Ulcers
        • Gastro Esophageal Reflux Disease (GERD)
        • Others
      • By Distribution Channel:
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
    • California
      • By Formulation:
        • Tablet
        • Liquid Suspension
          • Unit Dose Cup
          • Bottle
      • By Indication:
        • Gastric Ulcers
        • Duodenal Ulcers
        • Gastro Esophageal Reflux Disease (GERD)
        • Others
      • By Distribution Channel:
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
    • Others
      • By Formulation:
        • Tablet
        • Liquid Suspension
          • Unit Dose Cup
          • Bottle
      • By Indication:
        • Gastric Ulcers
        • Duodenal Ulcers
        • Gastro Esophageal Reflux Disease (GERD)
        • Others
      • By Distribution Channel:
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
  • Company Profiles
    • Teva Pharmaceutical Industries Ltd.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Allergan plc
    • Vertice Pharma LLC
    • Pharmaceutical Associates Inc.

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Formulation
      • Market Snippet, By Indication
      • Market Snippet, By Distribution Channel
      • Market Snippet, By State
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Epidemiology
    • Market Trends
    • Regulatory Scenario
    • Reimbursement Scenario
    • Merger and Acquisition Scenario
    • Key Highlights
    • PEST Analysis
  4. U.S. Sucralfate Market, By Formulation, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Tablet
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Liquid Suspension
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
        • Unit Dose Cup
        • Bottle
  5. U.S. Sucralfate Market, By Indication, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Gastric Ulcers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Duodenal Ulcers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Gastro Esophageal Reflux Disease (GERD)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  6. U.S. Sucralfate Market , By Distribution Channel, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Hospital Pharmacy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Retail Pharmacy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Online Pharmacy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  7. U.S. Sucralfate Market , By State, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, By State, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • Illinois
      • Market Size and Forecast, By Formulation, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Indication, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
    • Texas
      • Market Size and Forecast, By Formulation, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Indication, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
    • New York
      • Market Size and Forecast, By Formulation, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Indication, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
    • California
      • Market Size and Forecast, By Formulation, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Indication, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
    • Others
      • Market Size and Forecast, By Formulation, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Indication, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
  8. Competitive Landscape
    • Company Profiles
      • Teva Pharmaceutical Industries Ltd.
        • Company Overview
        • Formulation Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Allergan plc
        • Company Overview
        • Formulation Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Vertice Pharma LLC
        • Company Overview
        • Formulation Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Pharmaceutical Associates Inc. (PAI)
        • Company Overview
        • Formulation Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 22 market data tables and 17 figures on "Sucralfate Market - U.S. forecast to 2026”.

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.